First Upgrade of Hydrogenated Hydrocarbon Resin Facility Completed by Eastman

Eastman Chemical Company has successfully completed the first of several upgrades of its hydrogenated hydrocarbon resin facility in Middelburg, the Netherlands. By the end of 2009, these combined upgrades will increase current capacity by more than 30%, and in total by 65% since 2006.

"Around the world, demand for Eastman Regalite hydrogenated hydrocarbon resins continues to increase," said Brad Lich, vice president and general manager of Eastman's coatings, adhesives, specialty polymers and inks business. "This investment in hydrogenated hydrocarbon resins reconfirms Eastman's commitment to enhancing our position as a global leader. It is an important next step in the globalization of our Regalite product line and allows us to serve customers not only in Europe, but in other regions of the world as well."

"We are pleased with this expansion," said Rien Jonker, site manager at Middelburg. "It will leverage our recent investments at the Middelburg site, and increase our capability to meet the market's current and future supply needs."

The Middelburg tackifier resin plant is one of the largest in the world, producing a range of rosin and hydrocarbon resins and dispersions. Regalite hydrogenated hydrocarbon resins have been produced since 1985, and are used extensively in a wide variety of hot melt adhesives, polymer compounds and plastic modifications. Thanks to their versatility and broad compatibility, Regalite hydrogenated hydrocarbon resins can be formulated with a wide range of Styrenic and Polyolefinic polymers, and offer excellent color, stability and adhesion.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.